The Fund Grade · free · no account needed

What grade does FSCHX get?

Morningstar rates funds on what they returned. We grade them on where their money sits today: how much of the book overlaps with the converged buys of the top specialist stock pickers.

A

Fundprints Fund Grade · as of 2026-10-30

Fidelity Select Chemical Pt

#4 of 363 graded active funds · blend · mid segment peer group

The point · specialist footprint

FSCHX puts more of its book behind proven specialists than 66% of graded funds.

Bottom 20%

Bottom 40%

Middle

● Top 40%

Top 20%

beat the S&P in 22% of quarters+3.8%/qtr better · 43% beat rate

That has mattered: over the past 2.7 years, funds on this rung beat bottom-rung funds by about 3.8% per quarter, and beat the S&P in 43% of fund-quarters versus their 22%. The evidence argues this fund earns its seat.

10,000+ funds tracked · the graded specialists among them drive every read

The grade scores this fund's specialist share, the slice that overlaps what the top 1% of proven funds are building. We ignore index ballast and names outside our edge on purpose: that slice is small, and it's what decides the outcome.

FSCHX vs the Honor Roll · share card ↗

Conviction exposure

30.2%

of the book in specialist-converged names

Late-stage weight

5.4%

of the book in Crowded or Fading names

Active share

98.9%

how far it strays from the index

The best grades have beaten the worst by about +5% a year since we began grading. The gap held in 9 out of 10 months. Measured on filings as they were published, no hindsight.

Inside the book: top names by stage · as of 2026-10-30

Early Conviction
SHW 15.3%ESI 7.3%ECL 4.2%+5 locked
Consensus
LIN 24.8%APD 4.3%PPG 4.3%+9 locked
Emerging
OLN 1.3%WLK 1%CC 0.8%+1 locked
Fading
CTVA 4.9%TROX 0.2%FMC 0.1%

We email you the day it crosses 50% crowded, and where you stand every month.

Graded monthly from point-in-time filings. A description of where the money sits, not a recommendation. Evidence, not advice.

The read · what to do with it

FSCHX earns an A grade and ranks 4th out of 363 graded funds, with specialists holding 30.2% of the fund. The most striking detail is that SHW makes up 15.3% of the portfolio at an Early Conviction stage, meaning proven specialists are still building that position early. ESI and ECL are also in early stages, while CTVA sits at 4.9% with specialists now leaving.

→ Watch the CTVA position closely, as specialists are fading from a 4.9% weight that still matters to returns.

→ The Early Conviction signal on SHW at 15.3% is the clearest reason the A grade holds; monitor if that stage shifts.

Support leaving these positions

CTVA 4.9% of the fund · Fading

TROX 0.2% of the fund · Fading

FMC 0.1% of the fund · Fading

Where it's genuinely early

SHW 15.3% of the fund · Early Conviction

ESI 7.3% of the fund · Early Conviction

ECL 4.2% of the fund · Early Conviction

Read from today's disclosed book. Evidence, not advice.

Find out whether you're early or late. It costs nothing.

Create your free account